INTERCEPT ANNOUNCES NEW CLINICAL TRIAL AND REAL-WORLD OUTCOMES DATA FOR OCALIVA IN PBC
COBALT study in advanced PBC, previously terminated early due to feasibility challenges, did not demonstrate a statistically significant difference in clinical endpoints between Ocaliva® and placebo HEROES-US real-world analysis demonstrated statistically...